Innoviva - 8 Year Stock Price History | INVA

Historical daily share price chart and data for Innoviva since 2016 adjusted for splits and dividends. The latest closing stock price for Innoviva as of February 29, 2024 is 15.28.
  • The all-time high Innoviva stock closing price was 20.25 on February 16, 2022.
  • The Innoviva 52-week high stock price is 16.86, which is 10.3% above the current share price.
  • The Innoviva 52-week low stock price is 10.64, which is 30.4% below the current share price.
  • The average Innoviva stock price for the last 52 weeks is 13.48.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Innoviva Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 16.0749 16.3700 16.7800 15.2800 15.2800 -4.74%
2023 12.9066 13.2700 16.2700 10.7300 16.0400 21.06%
2022 15.2545 17.4500 20.2500 11.6100 13.2500 -23.19%
2021 14.1809 12.4800 18.7200 11.0600 17.2500 39.23%
2020 12.5714 13.9300 15.2600 8.1100 12.3900 -12.50%
2019 13.6159 17.3000 20.0600 10.0500 14.1600 -18.85%
2018 15.2612 14.4300 18.2600 13.4400 17.4500 22.97%
2017 12.7225 11.1400 14.7500 10.4300 14.1900 32.62%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $0.984B $0.331B
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $719.883B 119.88
Novo Nordisk (NVO) Denmark $545.415B 44.93
Johnson & Johnson (JNJ) United States $389.136B 15.49
Merck (MRK) United States $324.660B 85.46
AbbVie (ABBV) United States $314.432B 16.02
Novartis AG (NVS) Switzerland $216.666B 15.01
AstraZeneca (AZN) United Kingdom $202.610B 17.95
Pfizer (PFE) United States $152.689B 14.78
Sanofi (SNY) $121.420B 10.93